BioTime (BTX) Misses Q3 EPS by 3c

BioTime (NYSE: BTX) reported Q3 EPS of ($0.12), $0.03 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $1.7 million, versus $1.5 million reported last year.

For earnings history and earnings-related data on BioTime (BTX) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c